Optimal Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$8.3M Buy
35,931
+39
+0.1% +$9.63K 1.04% 9
2021
Q2
$8.24M Hold
35,892
0.98% 9
2021
Q1
$6.71M Sell
35,892
-674
-2% -$132K 0.87% 14
2020
Q4
$6.17M Sell
36,566
-36
-0.1% -$5.38K 0.88% 14
2020
Q3
$5.42M Sell
36,602
-425
-1% -$65.8K 0.78% 20
2020
Q2
$6.08M Sell
37,027
-40,427
-52% -$6.21M 0.99% 5
2020
Q1
$10.7K Buy
77,454
+42,869
+124% +$5.89M 1.01% 6
2019
Q4
$4.55M Buy
+34,585
New +$4.01M 0.69% 23

Other funds holding LLY

Optimal Asset Management's LLY Position: Q3 2021 in Review

Optimal Asset Management increased its Eli Lilly (LLY) stake by 0.11% in Q3 2021, buying an estimated $9.63K and bringing the position to 35,931 shares worth $8.3M. The position accounts for 1.04% of the portfolio, ranked #9.

Optimal Asset Management first reported a position in LLY in Q4 2019 and has held it in 8 quarters since. 2,050 funds tracked by Wall St. Rank hold LLY as of Q3 2021.

  • Optimal Asset Management held 35,931 shares of Eli Lilly worth $8.3M as of Q3 2021.
  • Optimal Asset Management bought 39 Eli Lilly shares in Q3 2021, an estimated $9.63K.
  • Eli Lilly made up 1.04% of Optimal Asset Management's portfolio in Q3 2021, its #9 holding.
  • Optimal Asset Management first reported a position in Eli Lilly in Q4 2019 and has held it in 8 quarters since.
  • 2,050 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.